Greater caution on anemia drugs seen after deaths
Mon, 29 Jan 2007 01:41 PM EST
... NEW YORK (Reuters) - The higher mortality risk revealed in a trial of Amgen Inc.'s Aranesp and similar anemia medicines underscores the need to restrict their use and better understand how they work, analysts and drugmakers say. ...
Related Topics
- Anemia
- Sickle Cell Anemia
- Aplastic Anemia
- Pernicious Anemia
- Iron Deficiency Anemia
- X-linked sideroblastic anemia
- Sickle Cell
- Cooley's Anemia
- Thalassemia
- Anticancer Drugs
- Date Rape Drugs
- Disease-modifying anti-rheumatoid drugs
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Occipital Neuralgia
- Megaloblastic anemia
- General anemia
- Folate deficiency anemia
- Vitamin deficiency anemia
- Anemia in Kidney Disease and Dialysis
- Immune Globulin Intramuscular Injection

Not Signed In -


